Norwich Pharma Competitors and Similar CompaniesClear all

Norwich Pharma's competitors and similar companies include Avara Pharmaceutical Services, Shilpa Medicare, Anthem Biosciences and Quotient Sciences.

	Norwich Pharma Norwich is a company that provides contract manufacturing and clinical services.	Avara Pharmaceutical Services Avara Pharmaceutical Services is a provider of contract manufacturing and packaging of oral solid dose and liquid sterile drug products.	Shilpa Medicare Shilpa Medicare is a company that manufactures and markets generic active pharmaceutical ingredients (APIs) and formulations.	Anthem Biosciences Anthem Biosciences is a contract research organization providing services for pharmaceuticals, biotechnology, and chemistry sectors.	Quotient Sciences Quotient Sciences is a contract development and manufacturing organization.
Founding Date	Founding Date 1887	Founding Date 2016	Founding Date 1987	Founding Date 2006	Founding Date 1990
Type	Type Subsidiary	Type Private	Type Public	Type Private	Type Subsidiary
Tags	Tags Healthcare biotech contractor packaging pharma	Tags Healthcare contractor packaging pharma	Tags Healthcare biotech contractor pharma	Tags Healthcare biotech contractor pharma	Tags Healthcare biotech contractor pharma
Locations	Locations HQ	Locations Norman, US HQ Liscate, IT Aiken, US	Locations Raichur, IN HQ Bengaluru, IN Chicksugur, IN Devarsugur, IN Polepally, IN Secunderabad, IN Doylestown, US	Locations Bengaluru, IN HQ	Locations Ruddington, GB HQ Edinburgh, GB Reading, GB Boothwyn, US Garnet Valley, US Miami, US
Employees	Employees 1871% increase	Employees 5462% increase	Employees 1,007	Employees 2,1962% increase	Employees 980
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹12.9b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) £70.6m (FY, 2021)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹4.1b (FY, 2025)	Cost of goods N/A	Cost of goods £34.1m (FY, 2021)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ₹8.9b (FY, 2025)	Gross profit N/A	Gross profit £36.5m (FY, 2021)
Net income	Net income N/A	Net income N/A	Net income ₹783m (FY, 2025)	Net income N/A	Net income £13.4m (FY, 2021)
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 25.5m	Total funding raised N/A	Total funding raised $ 35m